Uncategorized

Pinchar los virus para matarlos. Esto, dicho de modo simplificado, es lo que han logrado unos científicos que han diseñado y fabricado una superficie capaz de mitigar el potencial infeccioso de virus mediante la acción mecánica, sin el uso de productos químicos. & …

Una de las razones por las que se eligieron a pilotos de pruebas para los primeros lanzamientos tripulados fue la necesidad de disponer de personas capaces de afrontar situaciones extremas. Poco se conocía del espacio y menos aún sobre si un ser humano sería capaz psicoló …

ArriVent BioPharma, Inc. announced the pricing of its upsized initial public offering of 9,722,222 shares of its common stock at a public offering price of $18.00 per share.

Sagimet Biosciences Inc. announced the pricing of its underwritten public offering of 9,000,000 shares of its Series A common stock at a public offering price of $12.50 per share.

Vanda Pharmaceuticals Inc. announced that the U.S. Patent and Trademark Office has issued a notice of allowance for its PONVORY® patent application, number 17/962,968, covering methods for reducing clinical management events before or during the treatment of multiple sclerosis and methods for reinitiating treatment after missed doses.

Asociaciones dosis-respuesta de rasgos lipídicos con enfermedad arterial coronaria y mortalidad

The Federal Trade Commission filed a lawsuit on Thursday to block Winston-Salem, North Carolina-based Novant Health from expanding its grip on healthcare in the state, warning a buy would increase costs.

The legislation would remove the requirement that Medicare beneficiaries be seen in-person within six months of receiving mental healthcare via telehealth.

During an annual address, executives outlined plans to build sustainably — with technology investments —  after the operator posted a profit last year.

The resources serve as a “step forward” as the agency looks to propose enforceable standards, HHS Deputy Secretary Andrea Palm said.